[go: up one dir, main page]

GB201914468D0 - Binding Molecules - Google Patents

Binding Molecules

Info

Publication number
GB201914468D0
GB201914468D0 GB201914468A GB201914468A GB201914468D0 GB 201914468 D0 GB201914468 D0 GB 201914468D0 GB 201914468 A GB201914468 A GB 201914468A GB 201914468 A GB201914468 A GB 201914468A GB 201914468 D0 GB201914468 D0 GB 201914468D0
Authority
GB
United Kingdom
Prior art keywords
binding molecules
molecules
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201914468A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Crescendo Biologics Ltd
Original Assignee
Crescendo Biologics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crescendo Biologics Ltd filed Critical Crescendo Biologics Ltd
Priority to GB201914468A priority Critical patent/GB201914468D0/en
Publication of GB201914468D0 publication Critical patent/GB201914468D0/en
Ceased legal-status Critical Current

Links

GB201914468A 2019-10-07 2019-10-07 Binding Molecules Ceased GB201914468D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB201914468A GB201914468D0 (en) 2019-10-07 2019-10-07 Binding Molecules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201914468A GB201914468D0 (en) 2019-10-07 2019-10-07 Binding Molecules

Publications (1)

Publication Number Publication Date
GB201914468D0 true GB201914468D0 (en) 2019-11-20

Family

ID=68541465

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201914468A Ceased GB201914468D0 (en) 2019-10-07 2019-10-07 Binding Molecules

Country Status (1)

Country Link
GB (1) GB201914468D0 (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003000737A2 (en) 2001-06-21 2003-01-03 The Babraham Institute MOUSE μ LIGHT CHAIN LOCUS
WO2004076618A2 (en) 2003-02-26 2004-09-10 Babraham Institute Genetically modified non-human mammals and cells
WO2011133704A2 (en) 2010-04-20 2011-10-27 Whitehead Institute For Biomedical Researh Modified polypeptides and proteins and uses thereof
WO2012175741A2 (en) 2011-06-23 2012-12-27 Ablynx Nv Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
WO2013024059A2 (en) 2011-08-17 2013-02-21 Glaxo Group Limited Modified proteins and peptides
WO2014043509A2 (en) 2012-09-13 2014-03-20 Novartis Ag Antigen binding molecule with terminal modifications
WO2014140317A2 (en) 2013-03-15 2014-09-18 Nbe-Therapeutics Llc Method of producing an immunoligand/payload conjugate
WO2016062990A1 (en) 2014-10-22 2016-04-28 Crescendo Biologics Limited Transgenic mice

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003000737A2 (en) 2001-06-21 2003-01-03 The Babraham Institute MOUSE μ LIGHT CHAIN LOCUS
WO2004076618A2 (en) 2003-02-26 2004-09-10 Babraham Institute Genetically modified non-human mammals and cells
WO2011133704A2 (en) 2010-04-20 2011-10-27 Whitehead Institute For Biomedical Researh Modified polypeptides and proteins and uses thereof
WO2012175741A2 (en) 2011-06-23 2012-12-27 Ablynx Nv Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
WO2013024059A2 (en) 2011-08-17 2013-02-21 Glaxo Group Limited Modified proteins and peptides
WO2014043509A2 (en) 2012-09-13 2014-03-20 Novartis Ag Antigen binding molecule with terminal modifications
WO2014140317A2 (en) 2013-03-15 2014-09-18 Nbe-Therapeutics Llc Method of producing an immunoligand/payload conjugate
WO2016062990A1 (en) 2014-10-22 2016-04-28 Crescendo Biologics Limited Transgenic mice

Non-Patent Citations (17)

* Cited by examiner, † Cited by third party
Title
"Antibody Engineering", vol. 1, 2, 2010, SPRINGER-VERLAG
"Therapeutic Monoclonal Antibodies: From Bench to Clinic", 2009, WILEY
ANTOS ET AL.: "Curr Protoc Protein Sci.", April 2009
BRIAN K. KAYJILL WINTERJOHN MCCAFFERTY: "Phage Display of Peptides and Proteins: A Laboratory Manual", 28 October 1996, ACADEMIC PRESS
BRUSCHI, C.V.GJURACIC, K.: "Encyclopedia of Life Sciences", 2002, MACMILLAN PUBLISHERS LTD, NATURE PUBLISHING GROUP, article "Yeast Artificial Chromosomes"
CHEN ET AL., NATURE SCIENTIFIC REPORTS, vol. 6, 2016
CHOTHIALESK, J. MOL. BIOL., vol. 196, 1987, pages 901 - 917
CORDY ET AL., CLINICAL & EXPERIMENTAL IMMUNOLOGY, vol. 182, no. 2, pages 139 - 148
GOROVITS ET AL., THE AAPS JOURNAL, vol. 18, no. 2, March 2016 (2016-03-01)
GREENSAMBROOK ET AL.: "Molecular Cloning: A Laboratory Manual", 2012, COLD SPRING HARBOR LABORATORY PRESS
HOLLIGER, NAT BIOTECHNOL., vol. 23, no. 9, September 2005 (2005-09-01), pages 1126 - 36
KABAT ET AL., ANN. NY ACAD. SCI., vol. 190, 1971, pages 382 - 391
KABAT ET AL.: "Sequences of Proteins of Immunological Interest", 1991, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, NIH
MUYLDERMANS, J BIOTECHNOL., vol. 74, no. 4, June 2001 (2001-06-01), pages 277 - 302
TON-THAT ET AL., PROC NATL ACAD SCI USA, vol. 96, no. 22, 26 October 1999 (1999-10-26), pages 12424 - 12429
WARD ET AL., NATURE, vol. 341, 1989, pages 544 - 546
ZAKERI ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 109, no. 12, March 2012 (2012-03-01), pages E690 - E697

Similar Documents

Publication Publication Date Title
IL281901A (en) Multivalent igm- and iga-fc-based binding molecules
IL273631A (en) Hpv-specific binding molecules
GB201901306D0 (en) Multi-domain binding molecules
IL289867A (en) Immunostimulatory multimeric binding molecules
GB201811408D0 (en) CD137 Binding Molecules
GB201901305D0 (en) Specific binding molecules
IL289415A (en) Claudin-6 binding molecules and uses thereof
IL288314A (en) Anti-tdp-43 binding molecules and uses thereof
GB201612520D0 (en) Binding molecules
GB201811410D0 (en) OX40 Binding molecules
IL287555A (en) Binding molecules
GB202006629D0 (en) Specific binding molecules
GB201702091D0 (en) Specific binding molecules
GB201915282D0 (en) Specific binding molecules
IL288561A (en) Anti-gal9 immune-inhibiting binding molecules
IL289266A (en) Novel molecules
SG11202109535SA (en) Cd3 binding molecules
IL269752B (en) Fgfr3 binding molecules
GB202010329D0 (en) Specific binding molecules
GB201803178D0 (en) Specific binding molecules for htert
SG11202113222PA (en) Activating anti-gal9 binding molecules
GB201906118D0 (en) Anti-LAG-3 binding molecules
GB201904328D0 (en) Specific binding molecules
ZA202200734B (en) Binding members
GB201912657D0 (en) Binding members

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)